Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
MYO vs MYSZ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
MYO Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–2 Matrix Metrics)
MYO Overall Winner
6-Pillar Tally: MYO 4 – 1 MYSZ (1 Tie)
Matrix Metrics: MYO 6 – 2 MYSZ
As of Nov 20, 2026, Myomo Inc. (MYO) is the stronger overall head-to-head candidate over My Size, Inc (MYSZ) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MYO carries a Unified Composite Score of 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin), whereas MYSZ carries 56.6/100 (HOLD) at $0.87 (N/M Forward P/E, -71.6% operating margin).
- Composite vs. Pillar Nuance: While MYSZ currently prints a higher short-term Unified Composite Score (56.6/100 HOLD vs. MYO 40.1/100 SELL), MYO captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-21.8% vs. -71.6% operating margin) and revenue trajectory (+22.2% vs. -27.8% YoY).
- Technical & Structure Timing Caution: MYO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7); meanwhile MYSZ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About MYO vs MYSZ
MYO
Head-to-Head Winner
Myomo Inc.
$0.81
-3.45% 1D
Market Cap
$33.7M
TTM Revenue
$46M
Forward P/E
N/M
Beta / 30D Vol
2.22β · 107% Vol
Unified Composite Score
40.1
SELL
Tech 25.0
Fund 43.0
Flow 58.0
Mom 59.0
Weinstein Technical Phase
Markdown · Sell / avoid
MYSZ
My Size, Inc
$0.87
+22.51% 1D
Market Cap
$838,691
TTM Revenue
$11M
Forward P/E
N/M
Beta / 30D Vol
3.20β · 116% Vol
Unified Composite Score
56.6
HOLD
Tech 68.0
Fund 60.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (MYO 4 – 1 MYSZ)
1. Valuation Multiples
MYSZ
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
0.9x
0.1x
2. Growth & Scale
MYO
Revenue Growth (YoY)
+22.2%
-27.8%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$46M
$11M
Market Cap
$33.7M
$838,691
3. Profitability & Quality
MYO
Gross Margin
70.1%
27.8%
Operating Margin
-21.8%
-71.6%
Net Profit Margin
-33.1%
-75.6%
Return on Equity (ROE)
-173.5%
-150.6%
4. Balance Sheet & Cash Flow
MYO
Cash Generation (TTM)
-$9.1M
-$7.1M EBITDA
Cash Flow Margin
-20.0%
-66.5% EBITDA Mgn
Net Cash / Leverage
$8.9M Net Debt (3.44x D/E)
$625,000 Net Debt (0.32x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
MYO
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
266.0% (81st %ile)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Medical Devices Operator
Apparel Retail Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: MYO (6) vs MYSZ (2)| Institutional Metric | MYO | MYSZ | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $33.7M | $838,691 | MYO | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | +22.2% | -27.8% | MYO | |
| Operating Margin (TTM) | -21.8% | -71.6% | MYO | |
| Net Profit Margin | -33.1% | -75.6% | MYO | |
| Return on Equity (ROE) | -173.5% | -150.6% | MYSZ | |
| 52-Week Range Position | 16% ($1–$2) | 14% ($0–$4) | MYO | |
| Beta / 30D Volatility | 2.22β · 107% Vol | 3.20β · 116% Vol | MYO | |
| Unified Institutional Score | 40.1 / 100 (SELL) | 56.6 / 100 (HOLD) | MYSZ | |
| Trailing 12M Revenue (USD) | $46M | $11M | Scale | |
| Gross Profit Margin (TTM) | 70.1% | 27.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 0.9x EV/Rev | N/M PEG · 0.1x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$9.1M ($8.9M Net Debt (3.44x D/E)) | -$7.1M EBITDA ($625,000 Net Debt (0.32x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
MYSZ +17.15 pp
3M Horizon
MYO +24.9 pp
6M Horizon
MYSZ +99.53 pp
1Y Horizon
MYO +8.36 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MYO Revenue | MYSZ Revenue | MYO Op. Margin | MYSZ Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -430.8% | N/A | MYO |
| FY2019 | $0M | $0M | -281.3% | -9507.9% | MYO |
| FY2020 | $10M | $0M | -138.5% | -4328.2% | MYO |
| FY2021 | $10M | $0M | -74.1% | -8074.0% | MYO |
| FY2022 | $20M | $0M | -68.6% | -181.9% | MYO |
| FY2023 | $20M | $10M | -42.8% | -96.4% | MYO |
| FY2024 | $30M | $10M | -19.1% | -47.8% | MYO |
| FY2025 | $40M | $10M | -35.2% | -61.3% | MYO |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
MYO
UNCLASSIFIED
Current IV
266.0%
IV Percentile
81st %ile
Put/Call OI Skew
N/A
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact MYO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
MYSZ
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact MYSZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
MYO Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
MYSZ Moat Profile
Cyclical / Execution-Driven Positioning
Apparel Retail Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ MYO vs MYSZ Key Questions & Quantitative Answers
As of Nov 20, 2026, Myomo Inc. (MYO) is the stronger overall head-to-head candidate over My Size, Inc (MYSZ) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MYO carries a Unified Composite Score of 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin), whereas MYSZ carries 56.6/100 (HOLD) at $0.87 (N/M Forward P/E, -71.6% operating margin). Composite vs. Pillar Nuance: While MYSZ currently prints a higher short-term Unified Composite Score (56.6/100 HOLD vs. MYO 40.1/100 SELL), MYO captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-21.8% vs. -71.6% operating margin) and revenue trajectory (+22.2% vs. -27.8% YoY). Technical & Structure Timing Caution: MYO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7); meanwhile MYSZ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MYO leads the Growth & Scale pillar: MYO posts +22.2% YoY revenue growth and +0.0% YoY earnings growth on $46M TTM revenue (70.1% gross margin, -21.8% operating margin), compared with MYSZ at -27.8% YoY revenue growth and +0.0% YoY earnings growth on $11M TTM revenue (27.8% gross margin, -71.6% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), MYO cumulative revenue shifted +300.0% while MYSZ shifted +0.0%. In operating R&D and SG&A reinvestment, MYO deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MYSZ.
MYSZ screens cheaper on headline valuation multiples. MYO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-20.0% FCF margin), whereas MYSZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-66.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MYO (-173.5% ROE) versus MYSZ (-150.6% ROE) capital efficiency.
In options market volatility and institutional positioning, MYO carries 266.0% implied volatility (81st %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.22β · 107% Vol realized risk). By comparison, MYSZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.20β · 116% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
MYSZ vs MYO · Reverse Pair
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal